NIH Publishes Revisions to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines)

News & Announcements

NIH Publishes Revisions to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines)

Posted on April 4, 2024April 4, 2024

Share:

Image

Image

Image

NIH has revised the NIH Guidelines to specify biosafety practices for research involving gene drive modified organisms (GDMOs) in contained research settings. These revisions include:

Specifying the minimum containment requirement for research involving GDMOs;

Articulating considerations for risk assessment and additional responsibilities for Institutional Biosafety Committees (IBCs) and Biosafety Officers

NIH previously published a Request for Information (RFI) in August 2023 seeking

The revised version of the NIH Guidelines is available at https://osp.od.nih.gov/wp-content/uploads/NIH_Guidelines.htm . To assist IBCs, biosafety professionals, and investigators with implementation of these changes, OSP has developed a